Walden Group Healthcare M&A Blog

  • LumiThera Acquires Diopsys

    LumiThera Inc, a manufacturer of photobiomodulation (PBM) technologies that treat ocular damage and disease, has acquired Diopsys, Inc. a maker of electrophysiology (ERG) devices that analyze visual and neuro-visual disorders. The deal adds an established commercial U.S. sales force to LumiThera's EU sales team and a complimentary diagnostic and...
    Read More
  • The Walden Group Releases 2021 Year-end Strategic Healthcare M&A Report

    The Walden Group is pleased to provide access to its 2021 Year-end Strategic Healthcare M&A Report, which includes:       Key Market Developments       The Most Important M&A Deals       What the Leading CEOs are Saying       Top Deals > $100m in Transaction Value Announced or Closed in 2021       Performance of Leading...
    Read More
  • DePuy Synthes Acquires CrossRoads Extremity Systems

    DePuy Synthes, the orthopedics and neurosurgery division of J&J, has acquired CrossRoads® Extremity Systems from its majority investor, Healthpoint Capital. The deal adds a portfolio of implants and instruments for lower-extremity procedures. In December 2021, DePuy Synthes acquired Israeli-based OrthoSpin, maker of an robotic orthopedic...
    Read More
  • Smith & Nephew Acquires Engage Surgical for $135 Million

    Smith & Nephew, a $4.6b UK-based sports medicine, joint repair, surgical access and woundcare technology producer, has acquired, Engage Surgical, a developer of a proprietary cementless partial knee system. The deal distinguishes Smith & Nephew as the only medical device company offering both cemented and cementless partial knee implants...
    Read More
  • Exact Sciences Buys PreventionGenetics For $190m

    Exact Sciences, a $876m developer of cancer screening and diagnostic test products to detect colorectal, prostate and other cancers, has acquired PreventionGenetics, a genetic testing laboratory. The deal complements Exact Sciences' advanced cancer diagnostics portfolio and support its entrance into hereditary cancer testing. PreventionGenetics...
    Read More